Biotechnology Stocks II Performance Guide: Arcturus Therapeutics Holdings Inc. (ARCT)
ARCT has no dividends.
Table and Chart of ARCT Performance
See what a $1,000 investment in ARCT is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| ARCT Returns | |
|---|---|
| Start Date | May-30-2014 |
| Start Price | $119.77 |
| End Date | May-16-2024 |
| End Price | $30.50 |
| # Prices | 121 |
| Min Date | Dec-31-2018 |
| Min Price | $4.53 |
| Max Date | Aug-29-2014 |
| Max Price | $134.82 |
| Total Return | -74.53% |
| Annualized Return | -12.69% |
| Current Value of $1,000 Purchase | $255 |
| Number Returns | 7,260 |
| Average Return | 75.74% |
| Number Profitable Returns | 3,510 |
| Percent Profitable Returns | 48.35% |
| Number Unprofitable Returns | 3,750 |
| Percent Unprofitable Returns | 51.65% |
| Profitable to Unprofitable Returns Ratio | 0.94 |
| ARCT Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $821,420,000 |
| Beta | 2.654 | Price to Sales | 4.91 |
| Earnings per Share | $-4.0300 |
| PE Ratio | None |
| PE to Growth Ratio | None |
| Price to Book | 2.946 |
| PRICE DATA | |
| 52 Week High | $43.81 |
| 52 Week Low | $17.52 |
| Analyst Target Price | $74.57 |
| 50-Day Moving Average | $30.98 |
| 200-Day Moving Average | $29.44 |
| FINANCIAL DATA | |
| Revenue per Share | $4.662 |
| Revenue | $124,526,000 |
| Profit Margin | -86.2% |
| Return on Equity | -36.2% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
ARCT Compare Returns with S&P 500
ARCT Trendline Chart
ARCT Moving Average Chart
ARCT Stock Return Map - See Patterns of Gains and Losses
ARCT Stock Returns/Purchase Dates